Intermittent prenatal MDMA exposure alters physiological but not mood related parameters in adult rat offspring

Behavioural Brain Research

Volumn 206, Issue 2, 2010, Pages 299-309

  Ádori, Csaba ^a   Zelena, Dóra ^b   Tímár, Júlia ^a   Gyarmati, Zsuzsa ^a   Domokos, Ágnes ^b   Sobor, Melinda ^a,c   Fürst, Zsuzsanna ^a   Makara, Gábor ^b   Bagdy, György ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Orszagos Gyogyszereszeti Intezet   (Hungary)

Author keywords

Depression; Hypothalamo pituitary adrenal axis; Locomotion; MDMA (ecstasy); Prenatal; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CORTICOSTERONE; GLUCOSE; PROOPIOMELANOCORTIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; FOOD PREFERENCE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; MALE; MOTOR COORDINATION; MUSCLE STRENGTH; NONHUMAN; ORGAN WEIGHT; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PSYCHOMOTOR DISORDER; RAT; ROTAROD TEST; SPLEEN WEIGHT; SWIMMING; THYMUS WEIGHT; WEIGHT REDUCTION;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BODY WEIGHT; CORPUS STRIATUM; CORTICOSTERONE; EXPLORATORY BEHAVIOR; FEMALE; HEMATOCRIT; HIPPOCAMPUS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAZE LEARNING; MOTOR ACTIVITY; MOTOR SKILLS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; ORGAN SIZE; PITUITARY GLAND; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRO-OPIOMELANOCORTIN; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RNA, MESSENGER; ROTAROD PERFORMANCE TEST; SPATIAL BEHAVIOR; SPLEEN; THYMUS GLAND; TRYPTOPHAN HYDROXYLASE; TYROSINE 3-MONOOXYGENASE;

EID: 70350524971     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.09.031     Document Type: Article

References (60)

1. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55 3 (2003) 463-508
2. de la Torre R., Farre M., Roset P.N., Pizarro N., Abanades S., Segura M., Segura J., and Cami J. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 26 2 (2004) 137-144
3. Rothman R.B., Baumann M.H., Dersch C.M., Romero D.V., Rice K.C., Carroll F.I., and Partilla J.S. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39 1 (2001) 32-41
4. Brown P.L., and Kiyatkin E.A. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions. Eur J Neurosci 20 1 (2004) 51-58
5. Molliver M.E., Berger U.V., Mamounas L.A., Molliver D.C., O'Hearn E., and Wilson M.A. Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci 600 (1990) 649-661 discussion 661-4
6. Quate L., McBean D.E., Ritchie I.M., Olverman H.J., and Kelly P.A. Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the Dark Agouti rat. Psychopharmacology (Berl.) 173 3-4 (2004) 287-295
7. Pedersen N.P., and Blessing W.W. Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. J Neurosci 21 21 (2001) 8648-8654
8. Bateman A., Singh A., Kral T., and Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 10 1 (1989) 92-112
9. McElhatton P.R., Bateman D.N., Evans C., Pughe K.R., and Thomas S.H. Congenital anomalies after prenatal ecstasy exposure. Lancet 354 9188 (1999) 1441-1442
10. Draper E.S., Rankin J., Tonks A.M., Abrams K.R., Field D.J., Clarke M., and Kurinczuk J.J. Recreational drug use: a major risk factor for gastroschisis?. Am J Epidemiol 167 4 (2008) 485-491
11. Plessinger M.A. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 25 1 (1998) 119-138
12. Koprich J.B., Chen E.Y., Kanaan N.M., Campbell N.G., Kordower J.H., and Lipton J.W. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats. Neurotoxicol Teratol 25 5 (2003) 509-517
13. Pacifici R., Zuccaro P., Farre M., Pichini S., Di Carlo S., Roset P.N., Lopez C.H., Ortuno J., Segura J., Cami J., and de la Torre R. Immunomodulating activity of MDMA. Ann N Y Acad Sci 914 (2000) 215-224
14. Matthews S.G. Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 13 9 (2002) 373-380
15. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 151 Suppl 3 (2004) U49-62
16. Campbell N.G., Koprich J.B., Kanaan N.M., and Lipton J.W. MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment. Neurotoxicol Teratol 28 4 (2006) 459-465
17. Skelton M.R., Williams M.T., and Vorhees C.V. Developmental effects of 3,4-methylenedioxymethamphetamine: a review. Behav Pharmacol 19 2 (2008) 91-111
18. Dube F., and Amireault P. Local serotonergic signaling in mammalian follicles, oocytes and early embryos. Life Sci 81 25-26 (2007) 1627-1637
19. Galineau L., Belzung C., Kodas E., Bodard S., Guilloteau D., and Chalon S. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat. Brain Res Dev Brain Res 154 2 (2005) 165-176
20. Kelly P.A., Ritchie I.M., Quate L., McBean D.E., and Olverman H.J. Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain. Br J Pharmacol 137 7 (2002) 963-970
21. Aitken A.R., and Tork I. Early development of serotonin-containing neurons and pathways as seen in wholemount preparations of the fetal rat brain. J Comp Neurol 274 1 (1988) 32-47
22. Jeljeli M., Strazielle C., Caston J., and Lalonde R. Effects of ventrolateral-ventromedial thalamic lesions on motor coordination and spatial orientation in rats. Neurosci Res 47 3 (2003) 309-316
23. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 5604 (1977) 730-732
24. Duncko R., Kiss A., Skultetyova I., Rusnak M., and Jezova D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology 26 1 (2001) 77-89
25. Zelena D., Domokos A., Barna I., Mergl Z., Haller J., and Makara G.B. Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattleboro rats. Endocrinology 149 5 (2008) 2576-2583
26. Zelena D., Filaretova L., Mergl Z., Barna I., Toth Z.E., and Makara G.B. Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats. Am J Physiol Endocrinol Metab 290 2 (2006) E243-E250
27. Paxinos G.W.C. The rat brain in stereotaxic coordinates. 2nd ed. (1986), Academic Press Inc., San Diego, California
28. Adori C., Ando R.D., Kovacs G.G., and Bagdy G. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. J Comp Neurol 497 2 (2006) 251-269
29. Broening H.W., Morford L.L., Inman-Wood S.L., Fukumura M., and Vorhees C.V. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development. J Neurosci 21 9 (2001) 3228-3235
30. Ho E., Karimi-Tabesh L., and Koren G. Characteristics of pregnant women who use ecstasy (3,4-methylenedioxymethamphetamine). Neurotoxicol Teratol 23 6 (2001) 561-567
31. Piper B.J. A developmental comparison of the neurobehavioral effects of ecstasy (MDMA). Neurotoxicol Teratol 29 2 (2007) 288-300
32. Aguirre N., Barrionuevo M., Lasheras B., and Del Rio J. The role of dopaminergic systems in the perinatal sensitivity to 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rats. J Pharmacol Exp Ther 286 3 (1998) 1159-1165
33. Colado M.I., O'Shea E., Granados R., Misra A., Murray T.K., and Green A.R. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol 121 4 (1997) 827-833
34. Winslow J.T., and Insel T.R. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 254 1 (1990) 212-220
35. St Omer V.E., Ali S.F., Holson R.R., Duhart H.M., Scalzo F.M., and Slikker Jr. W. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats. Neurotoxicol Teratol 13 1 (1991) 13-20
36. Mordenti J.C.W. The use of interspecies scaling in toxicokinetics. In: Yacogi A.K., and Batra J. (Eds). Toxikokinetics and new drug development (1989), Pergamon Press, New York 42-96
37. Piper B.J., and Meyer J.S. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. Pharmacol Biochem Behav 79 4 (2004) 723-731
38. Yacoubian Jr. G.S., Arria A.M., Fost E., and Wish E.D. Estimating the prevalence of ecstasy use among juvenile offenders. J Psychoactive Drugs 34 2 (2002) 209-213
39. Winstock A.R., Wolff K., and Ramsey J. Ecstasy pill testing: harm minimization gone too far?. Addiction 96 8 (2001) 1139-1148
40. Fligny C., Fromes Y., Bonnin P., Darmon M., Bayard E., Launay J.M., Cote F., Mallet J., and Vodjdani G. Maternal serotonin influences cardiac function in adult offspring. FASEB J 22 7 (2008) 2340-2349
41. Amireault P., and Dube F. Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos. Biol Reprod 73 2 (2005) 358-365
42. Amireault P., and Dube F. Intracellular cAMP and calcium signaling by serotonin in mouse cumulus-oocyte complexes. Mol Pharmacol 68 6 (2005) 1678-1687
43. Vesela J., Rehak P., Mihalik J., Czikkova S., Pokorny J., and Koppel J. Expression of serotonin receptors in mouse oocytes and preimplantation embryos. Physiol Res 52 2 (2003) 223-228
44. Levin M., Buznikov G.A., and Lauder J.M. Of minds and embryos: left-right asymmetry and the serotonergic controls of pre-neural morphogenesis. Dev Neurosci 28 3 (2006) 171-185
45. Nebigil C.G., Launay J.M., Hickel P., Tournois C., and Maroteaux L. 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc Natl Acad Sci USA 97 6 (2000) 2591-2596
46. Cote F., Fligny C., Bayard E., Launay J.M., Gershon M.D., Mallet J., and Vodjdani G. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA 104 1 (2007) 329-334
47. Gerra G., Bassignana S., Zaimovic A., Moi G., Bussandri M., Caccavari R., Brambilla F., and Molina E. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity. Psychiatry Res 120 2 (2003) 115-124
48. Nash Jr. J.F., Meltzer H.Y., and Gudelsky G.A. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 245 3 (1988) 873-879
49. Levitt N.S., Lindsay R.S., Holmes M.C., and Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64 6 (1996) 412-418
50. Welberg L.A., Seckl J.R., and Holmes M.C. Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. Neuroscience 104 1 (2001) 71-79
51. Williams M.T., Schaefer T.L., Ehrman L.A., Able J.A., Gudelsky G.A., Sah R., and Vorhees C.V. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Res 1039 1-2 (2005) 97-107
52. Williams M.T., Morford L.L., Wood S.L., Rock S.L., McCrea A.E., Fukumura M., Wallace T.L., Broening H.W., Moran M.S., and Vorhees C.V. Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress. Brain Res 968 1 (2003) 89-101
53. Wilcoxon J.S., and Redei E.E. Maternal glucocorticoid deficit affects hypothalamic-pituitary-adrenal function and behavior of rat offspring. Horm Behav 51 3 (2007) 321-327
54. Mlynarik M., Zelena D., Bagdy G., Makara G.B., and Jezova D. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm Behav 51 3 (2007) 395-405
55. Buitrago M.M., Schulz J.B., Dichgans J., and Luft A.R. Short and long-term motor skill learning in an accelerated rotarod training paradigm. Neurobiol Learn Mem 81 3 (2004) 211-216
56. Pritchett K., and Mulder G.B. The rotarod. Contemp Top Lab Anim Sci 42 6 (2003) 49
57. Kirilly E., Molnar E., Balogh B., Kantor S., Hansson S.R., Palkovits M., and Bagdy G. Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days. Int J Neuropsychopharmacol 11 6 (2008) 795-809
58. Kovacs G.G., Ando R.D., Adori C., Kirilly E., Benedek A., Palkovits M., and Bagdy G. Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord. Neuropathol Appl Neurobiol 33 2 (2007) 193-203
59. Bakker J.M., Schmidt E.D., Kroes H., Kavelaars A., Heijnen C.J., Tilders F.J., and van Rees E.P. Effects of neonatal dexamethasone treatment on hypothalamo-pituitary adrenal axis and immune system of the rat. J Neuroimmunol 74 1-2 (1997) 69-76
60. Mueller B.R., and Bale T.L. Sex-specific programming of offspring emotionality after stress early in pregnancy. J Neurosci 28 36 (2008) 9055-9065